NRIM — Northrim BanCorp, Inc.

NRIM — Northrim BanCorp, Inc. — Deep-value analysis (REFRESH)

Analysis date: 2026-09-02 · Price: $25.38 (data pack yfinance + tracker, 2026-09-02) · Market cap: $564.6M · Sector: Financial Services / Banks – Regional · Exchange: NASDAQ · HQ: Anchorage, Alaska · CIK: 0001163370

REFRESH mode. The reference analysis is the one from 2026-07-28 (rapoarte/deep/2026-07-28-deep-NRIM.md, verdict MONITOR at a price of $26.74). The quarter-over-quarter table triage flagged a new filing (10-Q Q2 2026, filed 2026-07-31) and one unverifiable falsifier (the NIM engine). What I inherit and what I re-derive is stated explicitly at the start of each chapter.

New primary sources for this refresh: 10-Q Q2 2026 (filed 2026-07-31, accession 0001163370-26-000029, document nrim-20260630.htm) — not in the local file; the automated EDGAR downloader only downloads 10-Qs for a completed fiscal year, so I pulled it directly from EDGAR and converted it with the filing-text extractor. The rest: 10-K FY2025 (2026-03-06), DEF 14A (2026-04-14), the Q2 2026 results 8-K and the PBCO merger 8-K (both 2026-07-23).

---

Executive summary

What I inherit unchanged from the reference analysis: the business description and three-segment structure, the nature of the regional moat, the PBCO deal terms (1.160 ratio, ~$167.3M, ~21% dilution, closing Q4 2026/Q1 2027), management’s capital-allocation profile, the fact that the “302.9% dilution” in the data pack is an artifact of the 4-for-1 split on September 18, 2025, and the $57.44M owner-earnings base. None of these have moved: the new filing covers exactly the same quarter (Q2 2026) the July report had already analyzed from the July 22-23 8-K press release. The refresh doesn’t bring a new quarter of profit — it brings the exhibits behind the press release.

What I re-derive, and why it matters. The four tables in the 10-Q that the press release didn’t contain partially reverse the reference thesis’s most emphasized red flag:

1. Criticized loans FELL, they didn’t rise: $86,318 thousand (12/31/2025) → $68,996 thousand (06/30/2026), −20.1%; net of government guarantees $43,979 → $42,606 thousand, −3.1%. As a share of the portfolio: 3.76% → 2.89% [10-Q Q2 2026, Note 3, risk-rating-by-origination-year tables].
2. Potential problem loans fell by half: $21.2M (12/31/2025) → $11.5M (06/30/2026), and the 10-Q states explicitly why: “primarily due to the transfer of three loans to a single borrower to nonaccrual status, as well as paydowns” [10-Q, MD&A, “Potential problem assets”].
3. So the nonaccrual jump from $11.97M to $22.98M is not new deterioration — it’s the migration of an already-identified exposure from the watchlist into nonaccrual. The Community Banking segment’s net adversely classified assets are $28.9M at 06/30/2026 versus $32.1M at 06/30/2025: down 10% year-over-year, after rising 75% in Q2 2025 [10-Q, MD&A, Community Banking segment].
4. Actual losses are near zero: gross loan charge-offs $394 thousand in H1 2026, recoveries $71 thousand → $323 thousand net, i.e. 0.014% of the portfolio over six months. The loan provision was $2,047 thousand — 6.3× realized losses. The bank is building its reserve, not harvesting it.

What’s worsening, on the other hand — and this is a new finding, not inherited: the purchased receivables (factoring, Specialty Finance) book. It grew 20.8% in six months ($101.6M → $122.8M) while revenue from it grew 4.6% ($12,047 → $12,605 thousand), and its provision was zero for all of 2025 and all of Q1 2026, rebuilt only in Q2 2026 to $610 thousand = 0.49% of balance — on a book that in 2025 posted a net charge-off ratio of 2.16% of average balance [10-K FY2025, purchased receivables ACL table; 10-Q Q2 2026, Note 4]. Management’s own stated reason for rebuilding it is itself a signal: “an increase in concentration of these assets.”

Model correction — mandatory. The Monte Carlo simulation in the delta-triage pack is invalid: it received --oe 57443 (thousand USD) alongside --sh 22.11 (millions of shares), a 1000× unit error. That’s why it reported a median intrinsic value of $26,756.51/share and a median MOS of +103,849% — figures absurd on their face, but which would have passed unnoticed as a marker line. I reran it with correct units (--oe 57.443 --sh 22.544): median IV $26.24, median MOS +3.4%, undervaluation probability 54.0%. The same error existed in the reference report (its DEEPMC line was just as inflated) — so this isn’t a new regression, it’s an inherited error the refresh fixes.

The thesis, updated. Northrim remains an Alaska community bank with top-tier profitability for the sector (ROAE 17.7%, TTM adjusted ROTE 20.5%), trading at 8.2× TTM GAAP profit, 9.8× adjusted profit (excluding the $14.5M one-off gain from the Pacific Wealth Advisors sale) and 1.90× tangible book value. The growth engine — net interest margin expansion — is confirmed and more durable than I thought: of the +29 bp of NIMTE year-over-year (4.72% → 5.01%), only part comes from deposit repricing; the rest comes from the asset mix (loans rose from 75.19% to 79.29% of interest-earning assets) and from the securities portfolio rolling upward (yield 3.07% → 3.79%) — two favorable winds independent of the Fed’s next move.

Estimated value (5 triangulated models): from −8.7% (EPV at an 11% cost of capital) to +34.3% (excess-return P/TBV with a sustained 17% ROTE), with the base (median) at +3.0%. Monte Carlo across 20,000 scenarios: P10 −30.8%, P50 +3.4%, P90 +54.6%, P(undervalued) 54.0%. A wide range, centered on zero.

Verdict: MONITOR — unchanged from July, but with the reasons reweighted. Credit risk, which was reason #2 for caution in July, has materially eased in light of the 10-Q. PBCO execution risk remains intact and unmitigated. A new, concrete risk has appeared (under-provisioning of the factoring book). The stock is close to normalized intrinsic value; it doesn’t justify a firm conviction position at $25.38, but the qualitative thesis is more solid than it looked five weeks ago.

---